Organogenesis Holdings, Inc.
(NASDAQ : ORGO)

( )
ORGO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Finance » Financial Conglomerates
symbolcompany%chnglast%shortavg$volume
CCitigroup, Inc. -1.05%38.820.9%$1336.19m
AXPAmerican Express Co. -0.09%76.591.7%$774.35m
PRUPrudential Financial, Inc. -0.83%46.611.4%$270.16m
EQHEquitable Holdings, Inc. 0.37%13.410.0%$79.66m
INGING Groep NV -1.28%5.030.2%$64.38m
DEACDiamond Eagle Acquisition Corp. 4.08%12.250.0%$28.60m
VTIQVectoIQ Acquisition Corp. 1.98%10.800.0%$22.34m
CNNECannae Holdings, Inc. -5.62%29.540.0%$22.13m
FPACFar Point Acquisition Corp. -0.10%10.110.0%$12.49m
FBCFlagstar Bancorp, Inc. 1.39%18.221.3%$8.34m
PAEPAE, Inc. -2.30%6.370.0%$8.26m
EFCEllington Financial, Inc. -3.07%4.100.1%$5.65m
TRNETrine Acquisition Corp. 0.00%9.960.0%$5.61m
ALTAltimmune, Inc. -0.66%3.000.0%$5.52m
SHGShinhan Financial Group Co., Ltd. 1.94%22.130.1%$5.01m

Company Profile

Organogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.